相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells
Bingxia Shi et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma
Qian Lyu et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway
Jing Luo et al.
CANCER CELL INTERNATIONAL (2019)
Higher Expression of Linc00152 Promotes Bladder Cancer Proliferation and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway
Tang Xian-li et al.
MEDICAL SCIENCE MONITOR (2019)
Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis
Cuiping Li et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition
Rui Chen et al.
JOURNAL OF IMMUNOLOGY (2018)
Dual Roles for CXCL4 Chemokines and CXCR3 in Angiogenesis and Invasion of Pancreatic Cancer
Cathy Quemener et al.
CANCER RESEARCH (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
Clinical development of gene therapy: results and lessons from recent successes
Sandeep R. P. Kumar et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Targeting the canonical Wnt/-catenin pathway in hematological malignancies
Eishi Ashihara et al.
CANCER SCIENCE (2015)
FOXO3a modulates WNT/beta-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
Hao Liu et al.
CELLULAR SIGNALLING (2015)
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL447-70 and CXCL4L147-70 in an EGF-dependent breast cancer model
Katrien Van Raemdonck et al.
Oncotarget (2015)
Wnt signaling in adult intestinal stem cells and cancer
Michaela Krausova et al.
CELLULAR SIGNALLING (2014)
∼- catenin deacetylation is essential for WNT-induced proliferation of breast cancer cells
Shao-Hua Wang et al.
MOLECULAR MEDICINE REPORTS (2014)
CXCL4L1-fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis
A. C. Prats et al.
MICROVASCULAR RESEARCH (2013)
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3
Sofie Struyf et al.
BLOOD (2011)
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
Jo Vandercappellen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Functional divergence between 2 chemokines is conferred by single amino acid change
Alexandre Dubrac et al.
BLOOD (2010)
Oncolytic parvoviruses as cancer therapeutics
Jean Rommelaere et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: No shortcuts on the road to approval
Caroline J. Breitbach et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer
Hannelien Verbeke et al.
HUMAN PATHOLOGY (2010)
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo
Jo Vandercappellen et al.
MOLECULAR CANCER RESEARCH (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
Herve Acloque et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Global epidemiology of oral and oropharyngeal cancer
Saman Warnakulasuriya
ORAL ONCOLOGY (2009)
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells
Jo Vandercappellen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis
Sofie Struyf et al.
CANCER RESEARCH (2007)
Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis
S Struyf et al.
CIRCULATION RESEARCH (2004)
分享论文
